According to the World Health Organization (WHO), Dengue is a viral infection spread to humans by infected mosquitoes and is a leading cause of febrile illness among international travelers.
Based on the record-setting number of Dengue outbreaks in 2024, the WHO has classified Dengue as a grade 3 emergency, placing about four billion people at risk globally.
In recent years, the development of effective vaccines to prevent Dengue has been an essential factor in the global effort to reduce outbreaks.
Co-Administering Dengue and HPV Vaccines Found Compatible
Vaccine-Enhancing Adjuvant Library Launches
Scientists have launched the first-ever library of adjuvants that can be 'taken off the shelf' and used to enhance new vaccines being developed against epidemic and pandemic threats.
Announced on July 31, 2025, the UK's Medicines and Healthcare products Regulatory Agency (MHRA) will host a repository of 25 vaccine-enhancing adjuvants. The adjuvant library could help quickly identify the top-performing vaccine-adjuvant pairings.
Study Estimates COVID-19 Vaccinations Prevented More Than 2.5 Million Deaths in 2020 to 2024
Most life-years saved were among people aged 60 years or older; estimates are more conservative than those that focused on the first year of vaccination